Routine vitamin A supplementation and other high impact interventions in Sierra Leone. Issue 4 (27th July 2020)

• Record Type: Journal Article
• Authors: Koroma, Aminata S.; Conteh, Sulaiman G.; Bah, Mariama; Kamara, Habib I.; Turay, Mohamed; Kandeh, Abdulai; Macauley, Anna; Allieu, Henry; A. Kargbo, Anita; Sonnie, Mustapha; Hodges, Mary H.
• Is Part Of: Maternal and child nutrition. Volume 16:Issue 4(2020)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2020-07-27
• Subjects: child survival interventions -- complementary feeding -- deworming -- family planning -- immunization -- maternal health -- Sierra Leone -- teenage -- vitamin A supplementation; Children -- Nutrition -- Periodicals; Infants -- Nutrition -- Periodicals; Pregnancy -- Nutritional aspects -- Periodicals; Breastfeeding -- Periodicals; 363.8083
• DOI: 10.1111/mcn.13041
• Languages: English
• ISSNs: 1740-8695

Abstract

Abstract: In 2017, transition to routine vitamin A supplementation (VAS) commenced as an integrated reproductive and child health service including vaccinations, Albendazole for deworming, complementary feeding demonstrations, 'quality' family planning counselling and provision of modern contraceptives. After 10 months, a lot quality assurance sampling survey evaluated coverage of these interventions. Each of three districts was divided into five supervision areas (lots), and 19 villages were randomly selected in each lot proportional to population size. Households were randomly selected, and a questionnaire was administered to a caregiver of a child 6–11, 12–23 and 24–59 months in each village. Overall, caregivers of 855 children were interviewed, and 19 questionnaires were completed for each age group (6–11, 12–23 and 24–59 months) in each of the five lots in each district. All lots in one district passed the threshold of 80% for VAS and 75% coverage for Albendazole, and two lots failed for either VAS/Albendazole in the other two districts. Overall, weighted VAS coverage for children 6–59 months was 86.9%, and weighted Albendazole coverage for children 12–59 months was 80.9%. Most caregivers (77.2%) knew that complementary feeding should be introduced at 6 months, 44.9% were providing three or more (of six) food groups, 84.9% were aware of family planning and 37.5% were using a modern contraceptive. Integration of reproductive and child health services appears to be a suitable platform for routine VAS and Albendazole whilst improving complementary feeding practices and access to family planning.